Hepatitis C Medications: The Burchfield Group's focused look at Utilization

By Steve Anderson
Mon, Feb, 08, 2016 @ 08:02 AM


Hepatitis C medications have likely impacted your 2015 budget. They are poised to potentially impact future year’s budgets and may break your budget if you are not aware of how this category is impacting prescription spend and total health care costs. Analyzing the first year’s utilization in your plan will help you prepare better.


FDA approves Zarxio as the first U.S. biosimilar

Chris Hanson-Ehlinger
Wed, Mar, 11, 2015 @ 16:03 PM

Biosimilars drive competition, alleviate medication costs for plans

Chris Hanson-Ehlinger
Mon, Feb, 02, 2015 @ 14:02 PM

PBM formulary cuts preserve specialty access

Chris Hanson-Ehlinger
Wed, Jul, 16, 2014 @ 09:07 AM

Adjust your drug plan strategy to manage specialty medication costs

Chris Hanson-Ehlinger
Wed, Mar, 05, 2014 @ 14:03 PM
Privacy Policy